Truemed Receives Validation Institute’s Certification for High Clinical Standards in HSA and FSA Markets

Truemed Achieves Certification from Validation Institute

Truemed, a prominent player in the Health Savings Account (HSA) and Flexible Spending Account (FSA) marketplace, celebrates a significant milestone by receiving independent certification from the Validation Institute. This prestigious certification attests to Truemed’s highest standards of clinical rigor and contractual integrity, setting a new benchmark in the industry for preventive health products.

Founded with a mission to empower individuals to take control of their health through preventive measures, Truemed has established itself as the leading marketplace, catering to individuals looking for effective and accessible health solutions. The recent validation emphasizes the company’s commitment to evidence-based lifestyle interventions, which play a crucial role in long-term health outcomes.

According to Justin Mares, Truemed’s Founder and CEO, this certification underscores their dedication to integrating clinical excellence with accessibility, ensuring compliance with the complex frameworks of the IRS and ERISA. He remarked, “Our goal is to facilitate a process where preventive care is just as easy to finance as traditional treatment options, thereby promoting a healthier future.”

This validation by the Validation Institute, noted for critically assessing healthcare operations, positions Truemed at the forefront of the market. The Institute recognized Truemed as having the most clinically rigorous protocols compared to any other existing solutions, providing two salient guarantees: one for clinical credibility and the other pertaining to ERISA immunity.

The integration of licensed health practitioners in Truemed’s operational workflow ensures that all the products are evaluated for medical necessity, emulating traditional healthcare processes. This approach not only bolsters the credibility of the available solutions but also establishes a novel standard for other organizations in the health sector.

As a testament to the positive influence of non-drug therapies, industry leaders like Al Lewis, Founder and Validator-in-Chief of the Validation Institute, expressed their support for Truemed’s approach. He noted that the platform aids employees in accessing non-drug therapies that are often not covered under conventional health plans, providing alternatives that serve to complement traditional medical practices.

Truemed remains proud of its partnerships with a diverse range of over 3,000 merchants, which include well-known brands such as Peloton, Eight Sleep, Nike Strength, and 24 Hour Fitness. This extensive collaboration allows users to utilize their HSA/FSA funds effectively, facilitating access to a wide array of preventive health products, and addressing the growing chronic disease crisis in the country.

The company enjoyed a successful $34 million Series A funding round in late December 2025, led by the reputable Andreessen Horowitz, allowing them to further enhance their marketplace offerings and expand their reach in the health and wellness arena. In this landscape of healthcare solutions, Truemed stands out by making preventive care a financially feasible option for many, ensuring that consumers receive the best possible support in their wellness journeys.

By continuing to innovate and provide validated health solutions, Truemed is set to redefine how individuals can approach their health, emphasizing prevention as the first step toward a better quality of life. For more detailed information on Truemed and its offerings, visit www.truemed.com.